Launch · AI & Deep Tech

SwishX launches AI platform for pharma operations

By Startup Enthusiast · 12 August 2026

What they do

SwishX builds agentic AI tools for pharma sales, distribution, tenders and contracts

It launched four products after pivoting from device leasing startup Swish Club

The platform claims over $1 Mn ARR and expects $5 Mn contracted ARR by FY27

Swish Club raised $4.5 Mn in early 2024 for enterprise device procurement and leasing.
It shut down that business and rebranded as SwishX.
SwishX builds an agentic AI platform for pharma and medtech companies.
The platform targets commercial operations: sales, distribution, hospital contracts and government tenders.
It launched four products: Tender IQ, Contract IQ, Marketing IQ and Channel IQ.
SwishX uses Anthropic LLMs and Cartesia for voice capabilities.
It trained on 70,000+ pharma tenders in India plus datasets from the US and Brazil.

The Indian pharma industry is estimated at over $65 Bn and supplies about one-fifth of the world's medicines.
Swish Club was a capital-intensive device leasing business with thin differentiation.
The pivot moves SwishX into a high-margin software space with recurring revenue.

SwishX builds agentic AI agents for pharma commercial operations.
Tender IQ identifies tenders, matches product catalogues, assesses bid win probability and automates document preparation.
Contract IQ automates negotiations, approvals and contract execution between pharma companies and hospitals.
Marketing IQ converts brochures and PDFs into AI-generated short-form video for doctors.
Channel IQ streamlines interactions with retailers and distributors and improves channel visibility.
Each customer gets a sandboxed workspace; AI agents learn organisational preferences, approval processes and compliance requirements.
Learnings are never shared across accounts.
About 90% of intelligence comes from public data, 10% from proprietary learning layers; the company expects the ratio to reverse over time.
SwishX restricts agents to verified data sources like regulatory ones to minimise hallucinations and accuracy issues.